<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Cytogenetic studies were carried out in 18 patients with secondary <z:e sem="disease" ids="C0018939" disease_type="Disease or Syndrome" abbrv="">blood diseases</z:e>; 15 patients had a history of prior <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e>, two had been professionally exposed to <z:chebi fb="0" ids="50903">carcinogenic agents</z:chebi>, and one patient had been treated with immunodepressors </plain></SENT>
<SENT sid="1" pm="."><plain>The interval between initial therapy and <z:e sem="disease" ids="C0277555" disease_type="Disease or Syndrome" abbrv="">secondary disease</z:e> ranged from 13 to 123 months, with a mean of 57.8 months; the mean survival time from the diagnosis of <z:e sem="disease" ids="C0277555" disease_type="Disease or Syndrome" abbrv="">secondary disease</z:e> was 6 months </plain></SENT>
<SENT sid="2" pm="."><plain>Cytogenetic abnormalities were present in 83% of cases, with a trend to hypodiploidy in 90% </plain></SENT>
<SENT sid="3" pm="."><plain>The most often involved chromosomes were #5, #7, and 3p </plain></SENT>
<SENT sid="4" pm="."><plain>A correlation between the cytogenetic abnormalities and etiologic factors has been analyzed; data from the present series and from the literature suggest a correlation between chromosome #7 and chemical agents, and chromosomes #11, #12, and #17 and physical agents </plain></SENT>
</text></document>